Herantis Pharma’s Phase 2 Dry Eye study recruitment completed ahead of schedule
Herantis Pharma’s Phase 2 Dry Eye study recruitment completed ahead of schedule
An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye
Original Research
BioLight Reports Positive Clinical Study Findings for its TeaRx™ Diagnostic Parameters for Dry Eye Syndrome
Positive statistical correlations were identified
Optimizing Reading Tests for Dry Eye Disease
Results showed significantly lower rates in all reading tests in subjects with dry eye than in normal subjects
Automated Grading System for Evaluation of Superficial Punctate Keratitis Associated With Dry Eye
Different patterns of keratitis provide clues to the underlying disease, whereas
different amounts are indicative of severity.
Two Decades In Translation
For 20 years, “Therapeutic Topics” has explored ocular disease. Here’s an update on where translational medicine stands today.
Herantis Pharma has initiated Phase 2 study with Cis-UCA Eye Drops
Dry Eye Syndrome, results expected in Q3/2015
Dry eye therapy seeks to fill unmet need in artificial tears
A look at the history of artificial tears traces progression of products, dry eye market
3,500 Years of Artificial Tears
After three millennia of battling the discomfort and irritation of dry eye, is ophthalmology any closer to a solution?
Thoughts on Healing the Wounded Cornea
A look at the mechanism behind neurotrophic keratitis as well as current and future methods for treating it.